Supreme Court Outlines Principles Governing Exercise of Jurisdiction under Article 227  ||  Supreme Court Grants Anticipatory Bail to Pawan Khera in an FIR Filed by Assam Police  ||  SC Issues Guidelines on Summary Judgment in Commercial Suits under Order XIII-A CPC  ||  J&K&L High Court: Post-Conviction NDPS Bail Cannot Rest on Long Incarceration Alone  ||  Gauhati HC: Promotion Cannot be Withheld Merely Because Investigation is Pending Without Chargesheet  ||  Kar HC: Preventive Detention under Goonda Act Cannot Rest on Offences Committed During Juvenile Age  ||  Bombay HC: National Security Justifies Denial of Police Clearance Certificate  ||  Bombay HC: Comic Remarks Without Malicious Intent Not Religious Insult  ||  J&K&L High Court: Scandalous Allegations Against Judicial Officers in Pleadings Impermissible  ||  P&H HC: Writ Petition Against Private Trust's Contractual Employment Dismissed    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved